Literature DB >> 6998354

Depressed cell-mediated immunity in chronic dermatophytic infections.

Z Brahmni, B Liautaud, F Marill.   

Abstract

The immune response was studied in 10 patients with benign dermatophytosis and in 5 patients with a severe affection. At the humoral level no deficiencies were observed in both groups. However, all patients showed a marked and constant increase in IgE level. Skin test response in various concentrations of antigens as well as studies of activation of lymphocytes by specific and non-specific mitogens in vitro have demonstrated a depressed cell-mediated immunity. This anergy, however, is not an "all-or-one" phenomenon; it varies, and there seems to be a direct relationship between the state of anergy and the severity of the cases. Furthermore, certain discrepancies were observed between the in vivo and in vitro responses suggesting that defective cellular immune reactions in dermatophytosis may be symptomatic of a lack of some humoral factor and do not necessarily reflect an intrinsic cellular defect. Finally, among these 15 patients, 7 were brothers and sisters from 3 separate and unrelated families, suggesting an autosomal hereditary influence.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998354

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  3 in total

1.  Immunologic studies of three family members with the immunodeficiency with hyper-IgM syndrome.

Authors:  Z Brahmi; K H Lazarus; M E Hodes; R L Baehner
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

2.  Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis.

Authors:  D G Payan; L J Wheat; Z Brahmi; S Ip; W P Hansen; R A Hoffman; K Healey; R H Rubin
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

3.  Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats.

Authors:  J Weber; E Balish
Journal:  Mycopathologia       Date:  1985-04       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.